1987
DOI: 10.1212/wnl.37.5.768
|View full text |Cite
|
Sign up to set email alerts
|

Ganglioside monoclonal antibody (A2B5) labels Alzheimer's neurofibrillary tangles

Abstract: Ganglioside monoclonal antibody (A2B5) labels Alzheimer's neurofibrillary tangles both in isolated neurofibrillary tangle-bearing nerve cells and in partially purified preparations of tangle fibers. Antibody staining was preabsorbed by preincubation of antibody with neuronal ganglioside preparations. These results suggest that Alzheimer's neurofibrillary tangles have a ganglioside associated with them.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
14
0

Year Published

1989
1989
2012
2012

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(15 citation statements)
references
References 0 publications
1
14
0
Order By: Relevance
“…X-ray microprobe analysis of these intact prcPHF confirmed that they were nonproteinaceous in composition [19]. An independent laboratory has previously shown that neurofibrillary tangles could be immunolabeled in situ with a monoclonal antibody to a ganglioside [20]. They have since shown by immunoelectron microscopy that this antibody will immunolabel isolated, intact PHF [21].…”
Section: Introductionmentioning
confidence: 76%
“…X-ray microprobe analysis of these intact prcPHF confirmed that they were nonproteinaceous in composition [19]. An independent laboratory has previously shown that neurofibrillary tangles could be immunolabeled in situ with a monoclonal antibody to a ganglioside [20]. They have since shown by immunoelectron microscopy that this antibody will immunolabel isolated, intact PHF [21].…”
Section: Introductionmentioning
confidence: 76%
“…It is worthy to note that an aberrant expression of A2B5-positive gangliosides was observed in neurofibrillary tangles and dystrophic neurites in Alzheimer's disease brain [24,25] and that GD3 was highly enriched in the plaques of multiple sclerosis [26,27[. The elucidation of ganglioside marker in fetal human brain cell cultures might help us to better under stand the alterations in ganglioside biosynthesis in the human CNS disorders.…”
Section: Introductionmentioning
confidence: 99%
“…Regarding this, a variety of neurodegenerative disorders are associated with an increase in the amount of gangliosides in the cerebrospinal fluid [3][4][5]. And also, gangliosides have been localized to neurofibrillary tangles in brain tissue from AD patients, and Betz cells of the precentral gyrus in amyotrophic lateral sclerosis (ALS) patients [6][7][8]. Especially, GD1a was detected in dystrophic neurons and accumulated in some senile plaques, suggesting the contribution of senile plaques formation in AD brains [9].…”
mentioning
confidence: 99%